
News|Articles|July 1, 2026
Contemporary OB/GYN's top stories from the first half of 2026
Author(s)Joshua Fitch, Senior Editor
Fact checked by: Benjamin P. Saylor, Tracy Ann Politowicz
A reader-driven look at the 10 most-viewed articles on Contemporary OB/GYN from the first half of 2026, spanning FDA decisions, clinical research, and emerging treatments across menopause, contraception, endometriosis, and pelvic health.
Advertisement
Advertisement
The first 6 months of 2026 brought a wave of meaningful developments in women's health, and our readers made clear which stories resonated most. The following 10 articles represent the most-viewed content on Contemporary OB/GYN from January through June 2026, a list driven entirely by our audience, reflecting what clinicians are reading, sharing, and returning to most often.
Related to this article

A recap of the top headlines from Contemporary OB/GYN in September 2026, spanning ACOG's respiratory vaccine guidance to the launch of the Missed & Dismissed podcast.

A recap of the top videos and podcasts from Contemporary OB/GYN in September 2026, featuring expert interviews on salpingectomy, testosterone evidence, and more.

Wen Shen, MD, describes perimenopause as an opportunity for clinicians to revisit pregnancy-related risk factors and address cardiovascular health proactively.

Wen Shen, MD, highlights perimenopause as an important period for identifying health risks and supporting healthy aging beyond the menopausal transition.

Anita Nelson, MD, discusses the FDA's approval extending etonogestrel implant use to 5 years and the new REMS certification clinicians must complete by February 23, 2027.

Menopause proteomics were consistently associated with inflammatory brain aging and Alzheimer’s dementia risk across nearly 15,000 women in a new study published in Nature Medicine.
Advertisement
Advertisement


